Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:1960
gptkb:FDA |
| gptkbp:availability |
prescription
|
| gptkbp:can_be |
millions of women
|
| gptkbp:caused_by |
breakthrough bleeding
|
| gptkbp:contains |
hormones
|
| gptkbp:contraindication |
certain cancers
history of blood clots smoking over age 35 |
| gptkbp:developed_by |
gptkb:Gregory_Pincus
|
| gptkbp:first_introduced |
gptkb:1960
|
| https://www.w3.org/2000/01/rdf-schema#label |
The Pill
|
| gptkbp:is |
daily
|
| gptkbp:is_associated_with |
sexual liberation movements
|
| gptkbp:is_available_in |
various formulations
various dosages combination and progestin-only types |
| gptkbp:is_available_on |
generic medication
|
| gptkbp:is_considered |
a personal choice
a form of empowerment for women a key factor in family planning. a reliable contraceptive method a significant advancement in women's health safe for most women |
| gptkbp:is_discussed_in |
gptkb:academic_journal
public health campaigns ethical debates healthcare policy debates |
| gptkbp:is_effective_against |
ST Is
|
| gptkbp:is_evaluated_by |
clinical trials
|
| gptkbp:is_influenced_by |
cultural attitudes
|
| gptkbp:is_linked_to |
improved quality of life
informed consent practices increased risk of breast cancer increased risk of cervical cancer increased access to education for women reduced risk of endometrial cancer reduced risk of ovarian cancer |
| gptkbp:is_part_of |
women's health initiatives
contraceptive counseling reproductive rights discussions contraceptive options family planning methods contraceptive technology advancements reproductive health education |
| gptkbp:is_promoted_by |
healthcare providers
|
| gptkbp:is_studied_in |
long-term effects
|
| gptkbp:is_subject_to |
insurance coverage policies
|
| gptkbp:is_used_for |
birth control
|
| gptkbp:is_used_in |
menstrual regulation
|
| gptkbp:is_used_to |
manage menstrual disorders
prevent ovulation regulate hormonal imbalances |
| gptkbp:manufacturer |
various pharmaceutical companies
|
| gptkbp:reduces |
acne
|
| gptkbp:regulates |
gptkb:menstrual_cycle
government agencies |
| gptkbp:requires |
prescription
|
| gptkbp:side_effect |
nausea
weight gain headaches mood changes |
| gptkbp:suitable_for |
pregnant women
|
| gptkbp:treatment |
polycystic ovary syndrome
|
| gptkbp:type |
gptkb:drug
|
| gptkbp:bfsParent |
gptkb:Loretta_Lynn
|
| gptkbp:bfsLayer |
3
|